ATE396746T1 - Verwendung eines resinats zur herstellung einer formulierung zur beendigung des rauchens - Google Patents

Verwendung eines resinats zur herstellung einer formulierung zur beendigung des rauchens

Info

Publication number
ATE396746T1
ATE396746T1 AT02716134T AT02716134T ATE396746T1 AT E396746 T1 ATE396746 T1 AT E396746T1 AT 02716134 T AT02716134 T AT 02716134T AT 02716134 T AT02716134 T AT 02716134T AT E396746 T1 ATE396746 T1 AT E396746T1
Authority
AT
Austria
Prior art keywords
resinate
formulation
producing
quitting smoking
water
Prior art date
Application number
AT02716134T
Other languages
English (en)
Inventor
Simon Andrew Bellamy
Lyn Hughes
Mazin Nicola
Original Assignee
Rohm & Haas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rohm & Haas filed Critical Rohm & Haas
Application granted granted Critical
Publication of ATE396746T1 publication Critical patent/ATE396746T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34Tobacco-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Addiction (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Polyesters Or Polycarbonates (AREA)
AT02716134T 2002-01-18 2002-01-18 Verwendung eines resinats zur herstellung einer formulierung zur beendigung des rauchens ATE396746T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/GB2002/000199 WO2003061709A1 (en) 2002-01-18 2002-01-18 A method for preparing resinates

Publications (1)

Publication Number Publication Date
ATE396746T1 true ATE396746T1 (de) 2008-06-15

Family

ID=27589640

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02716134T ATE396746T1 (de) 2002-01-18 2002-01-18 Verwendung eines resinats zur herstellung einer formulierung zur beendigung des rauchens

Country Status (7)

Country Link
US (1) US20050169997A1 (de)
EP (1) EP1467769B1 (de)
JP (1) JP4268052B2 (de)
CN (1) CN1615156B (de)
AT (1) ATE396746T1 (de)
DE (1) DE60226899D1 (de)
WO (1) WO2003061709A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005013934A2 (en) * 2003-07-28 2005-02-17 Novartis Consumer Health S.A. Taste-masked composition of cationic exchange resin
WO2005053691A2 (en) * 2003-12-02 2005-06-16 Fertin Pharma A/S Nicotine delivery product and method for producing it
ATE448786T1 (de) * 2005-06-01 2009-12-15 Fertin Pharma As Verfahren zur herstellung eines nikotinzuführenden produkts
US20070003512A1 (en) * 2005-06-20 2007-01-04 Stockel Richard F Bisphosphonate resinates
CN117563570B (zh) * 2024-01-16 2024-03-15 西安金沃泰环保科技有限公司 一种用于蛋白吸附的树脂及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2990332A (en) * 1958-04-02 1961-06-27 Wallace & Tiernan Inc Pharmaceutical preparations comprising cation exchange resin adsorption compounds and treatment therewith
DE1617513C3 (de) * 1965-08-20 1974-04-18 F. Hoffmann-La Roche & Co. Ag, Basel (Schweiz) Arzneimittelzubereitung
NL167303C (nl) * 1970-07-22 Leo Ab Vormstukken van kauwgom, bestaande uit een kauwgomba- sismassa, een tabaksalkaloide en eventueel andere ge- bruikelijke bestanddelen van kauwgom.
IL90245A (en) * 1988-05-11 1994-04-12 Glaxo Group Ltd Resin adsorbate comprising ranitidine together with a synthetic cation exchange resin, its preparation and pharmaceutical compositions containing it
GB8925484D0 (en) * 1989-11-10 1989-12-28 Glaxo Group Ltd Process
US5980882A (en) * 1997-04-16 1999-11-09 Medeva Pharmaceuticals Manufacturing Drug-resin complexes stabilized by chelating agents
WO2000040224A1 (en) * 1999-01-07 2000-07-13 Elan Corporation, Plc Multiparticulate oral dosage forms
US20020032245A1 (en) * 2000-07-27 2002-03-14 Lyn Hughes Resinate composition
US20020031490A1 (en) * 2000-07-27 2002-03-14 Bellamy Simon Andrew Method for preparing resinates
US6607752B2 (en) * 2000-07-27 2003-08-19 Rohm And Haas Company Method for the anhydrous loading of nicotine onto ion exchange resins

Also Published As

Publication number Publication date
CN1615156B (zh) 2012-05-30
EP1467769B1 (de) 2008-05-28
JP2005519068A (ja) 2005-06-30
DE60226899D1 (de) 2008-07-10
WO2003061709A1 (en) 2003-07-31
JP4268052B2 (ja) 2009-05-27
CN1615156A (zh) 2005-05-11
US20050169997A1 (en) 2005-08-04
EP1467769A1 (de) 2004-10-20

Similar Documents

Publication Publication Date Title
ATE431130T1 (de) Verwendung einer äusseren rückschicht zur herstellung eines implantierbaren pflasters zur arzneistoffabgabe
WO2003051275A3 (en) Benzodiazepine derivatives, preparation thereof and use thereof
NZ513356A (en) Method of modulating metabolite biosynthesis in recombinant cells using an AP2-domain transcription factor that is involved in the response of a plant cell to a jasmonate
GB2415142A (en) Porous matrix
CA2424579A1 (en) Ultraviolet-screening patch
NO2013002I1 (no) Aklidinium haogenid (Aklidinium bromid)
DE60036029D1 (de) Basismaterialien zur geweberegeneration, transplantatmaterialien und verfahren zur herstellung selbiger
DK1381402T3 (da) Fremgangsmåde til forbedring af blødvævsmodtagelse og implantater der gør brug af denne fremgangsmåde
EP1988253A3 (de) Verdrehsicherungsspray für Zementierstopfen
ATE396746T1 (de) Verwendung eines resinats zur herstellung einer formulierung zur beendigung des rauchens
EP1458870A4 (de) ZUSAMMENSETZUNGEN UND VERFAHREN ZUR VERWENDUNG VON siRNA, AMPHIPATISCHE VERBINDUNGEN UND POLYKATIONEN
ITMI20030640A1 (it) Procedimento per l'utilizzo di estratti organici ottenuti per lisciviazione acquosa di legno finalizzato alla preparazione di soluzioni organiche acidificanti per l'agricoltura biologica e concimi ad alta
NO980380L (no) Karbapenem antibiotika, preparat og fremstillingsmetode
ATE327972T1 (de) Verfahren zur herstellung von optisch-reinen (r)- und (s)- didesmethylsibutramin
SE0201713D0 (sv) New methods and use III
DE502004005201D1 (de) Verfahren zur herstellung eines extraktes aus efeublättern
ATE409719T1 (de) Verfahren zur herstellung fester treibmittelpräparationen
ID29676A (id) Metoda untuk memproduksi butiran pupuk yang dilapis
AU2001277659A1 (en) Heteropolycyclic inhibitors
WO2004066984A3 (en) Improved taste masking pharmaceutical composition and process for its preparation
DE60109494D1 (de) Verfahren zur herstellung von salbutamolisomeren
WO2004054354A3 (en) Carved pearl
ATE299878T1 (de) Verfahren zur herstellung von azacycloalkanoylaminothiazolen
EA200600400A1 (ru) Новая композиция, содержащая росиглитазон и другое противодиабетическое средство
ATE478065T1 (de) Verfahren zur herstellung von zusammensetzungen mit erhöhtem gehalt von salzen pharmazeutisch aktiver rotamere

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties